216 related articles for article (PubMed ID: 38021858)
1. The Impact of Contemporary Antiretroviral Drugs on Atherosclerosis and Its Complications in People Living With HIV: A Systematic Review.
Vemulapalli AC; Elias AA; Yerramsetti MD; Olanisa OO; Jain P; Khan QS; Butt SR
Cureus; 2023 Oct; 15(10):e47730. PubMed ID: 38021858
[TBL] [Abstract][Full Text] [Related]
2. The effects of ART on the dynamics of lipid profiles in Chinese Han HIV-infected patients: comparison between NRTI/NNRTI and NRTI/INSTI.
Liu S; Wei B; Liang W; Chen T; Deng L; Zhao M; Wan J
Front Public Health; 2023; 11():1161503. PubMed ID: 37181701
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study.
Corti N; Menzaghi B; Orofino G; Guastavigna M; Lagi F; Di Biagio A; Taramasso L; De Socio GV; Molteni C; Madeddu G; Salomoni E; Pellicanò GF; Pontali E; Bellagamba R; Celesia BM; Cascio A; Sarchi E; Gulminetti R; Calza L; Maggi P; Cenderello G; Bandera A; Carleo MA; Falasca K; Ferrara S; Martini S; Guadagnino G; Angioni G; Bargiacchi O; Ricci ED; Squillace N; Bonfanti P
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675955
[TBL] [Abstract][Full Text] [Related]
5. Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
Byonanebye DM; Polizzotto MN; Neesgaard B; Sarcletti M; Matulionyte R; Braun DL; Castagna A; de Wit S; Wit F; Fontas E; Vehreschild JJ; Vesterbacka J; Greenberg L; Hatleberg C; Garges H; Gallant J; Volny Anne A; Öllinger A; Mozer-Lisewska I; Surial B; Spagnuolo V; Necsoi C; van der Valk M; Mocroft A; Law M; Ryom L; Petoumenos K;
HIV Med; 2022 Sep; 23(8):895-910. PubMed ID: 35233903
[TBL] [Abstract][Full Text] [Related]
6. An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore.
Ang LW; Ng OT; Boudville IC; Leo YS; Wong CS
PLoS One; 2021; 16(6):e0252320. PubMed ID: 34077481
[TBL] [Abstract][Full Text] [Related]
7. Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected Patients.
Saumoy M; Sanchez-Quesada JL; Ordoñez-Llanos J; Podzamczer D
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441755
[TBL] [Abstract][Full Text] [Related]
8. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
[TBL] [Abstract][Full Text] [Related]
9. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis.
Islam FM; Wu J; Jansson J; Wilson DP
HIV Med; 2012 Sep; 13(8):453-68. PubMed ID: 22413967
[TBL] [Abstract][Full Text] [Related]
10. Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy-Update 2022: Systematic Review.
Amariles P; Rivera-Cadavid M; Ceballos M
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896248
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review.
Ruamtawee W; Tipayamongkholgul M; Aimyong N; Manosuthi W
BMC Public Health; 2023 Mar; 23(1):477. PubMed ID: 36915099
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer.
Torres HA; Rallapalli V; Saxena A; Granwehr BP; Viola GM; Ariza-Heredia E; Adachi JA; Chemaly RF; Marfatia R; Jiang Y; Mahale P; Kyvernitakis A; Fanale MA; Mulanovich V
Clin Microbiol Infect; 2014 Oct; 20(10):O672-9. PubMed ID: 24529214
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
[TBL] [Abstract][Full Text] [Related]
14. New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitors-based regimens: A systematic review and meta-analysis.
Kajogoo VD; Amogne W; Medhin G
Metabol Open; 2023 Mar; 17():100235. PubMed ID: 36923992
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy and weight gain in naive HIV-1 infected patient: a narrative review.
Dupont E; Cyr-Yombi J
AIDS Rev; 2022; 25(3):122-132. PubMed ID: 36343575
[TBL] [Abstract][Full Text] [Related]
16. Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.
Surial B; Chammartin F; Damas J; Calmy A; Haerry D; Stöckle M; Schmid P; Bernasconi E; Fux CA; Tarr PE; Günthard HF; Wandeler G; Rauch A;
Clin Infect Dis; 2023 Sep; 77(5):729-737. PubMed ID: 37157869
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis.
Snedecor SJ; Radford M; Kratochvil D; Grove R; Punekar YS
BMC Infect Dis; 2019 May; 19(1):484. PubMed ID: 31146698
[TBL] [Abstract][Full Text] [Related]
18. Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada.
Bourgi K; Jenkins CA; Rebeiro PF; Palella F; Moore RD; Altoff KN; Gill J; Rabkin CS; Gange SJ; Horberg MA; Margolick J; Li J; Wong C; Willig A; Lima VD; Crane H; Thorne J; Silverberg M; Kirk G; Mathews WC; Sterling TR; Lake J; Koethe JR;
J Int AIDS Soc; 2020 Apr; 23(4):e25484. PubMed ID: 32294337
[TBL] [Abstract][Full Text] [Related]
19. Integrase inhibitor-based regimens are related to favorable systemic inflammatory index and platecrit scores in people living with HIV (PLWH) up to 2 years.
Şahin EA; Mavi D; Kara E; Sönmezer MÇ; İnkaya AÇ; Ünal S
Postgrad Med; 2022 Aug; 134(6):635-640. PubMed ID: 35671079
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Syndrome Prevalence and Cardiovascular Risk Assessment in HIV-Positive Men with and without Antiretroviral Therapy.
Lu WL; Lee YT; Sheu GT
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34198775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
